Randomized study of low‐dose versus standard‐dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)-Reference-Cited by-同舟云学术

Randomized study of low‐dose versus standard‐dose chemoradiotherapy for unresectable esophageal squamous cell carcinoma (JCOG0303)

Published:2015-03-09 Issue:4 Volume:106 Page:407-412
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Shinoda Masayuki¹,Ando Nobutoshi²,Kato Ken³,Ishikura Satoshi⁴,Kato Hoichi⁵,Tsubosa Yasuhiro⁶,Minashi Keiko⁷,Okabe Hiroshi⁸,Kimura Yusuke⁹,Kawano Tatsuyuki¹⁰,Kosugi Shin‐Ichi¹¹,Toh Yasushi¹²,Nakamura Kenichi¹³,Fukuda Haruhiko¹³,

Affiliation:

1. Department of Thoracic Surgery Aichi Cancer Center Nagoya Japan

2. Department of Surgery Tokyo Dental College Ichikawa General Hospital Ichikawa Japan

3. Gastrointestinal Medical Oncology Division National Cancer Center Hospital Tokyo Japan

4. Department of Radiology Koshigaya Municipal Hospital Koshigaya Japan

5. Esophageal Surgical Division National Cancer Center Hospital Tokyo Japan

6. Esophageal Surgical Division Shizuoka Cancer Center Shunto‐Gun Japan

7. Division of Digestive Endoscopy and Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan

8. Department of Surgery Kyoto University Hospital Kyoto Japan

9. Department of Surgery Iwate Medical University Morioka Japan

10. Department of Esophageal and Gastric Surgery Tokyo Medical and Dental University Tokyo Japan

11. Department of Digestive and General Surgery Niigata University Niigata Japan

12. Department of Gastroenterological Surgery National Kyushu Cancer Center Fukuoka Japan

13. JCOG Data Center/Operations Office National Cancer Center Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.12622

Reference30 articles.

1. Role of Esophagectomy in Treatment of Esophageal Carcinoma with Clinical Evidence of Adjacent Organ Invasion

2. Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs

3. Phase II Study of Cisplatin and 5-Fluorouracil with Concurrent Radiotherapy in Advanced Squamous Cell Carcinoma of the Esophagus: a Japan Esophageal Oncology Group (JEOG)/Japan Clinical Oncology Group Trial (JCOG9516)

4. Esophagectomy: Is It Necessary after Chemoradiotherapy for a Locally Advanced T4 Esophageal Cancer? Prospective Nonrandomized Trial Comparing Chemoradiotherapy with Surgery versus without Surgery

Cited by 127 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term survival and post-hoc analysis of toripalimab plus definitive chemoradiotherapy for oesophageal squamous cell carcinoma: insights from the EC-CRT-001 phase II trial;eClinicalMedicine;2024-09

2. Validation of the cutoff values for the number of metastatic lymph nodes for esophageal cancer staging: a multi-institutional analysis of 655 patients in Japan;Esophagus;2024-08-24

3. Efficacy and Safety of Immune Checkpoint Inhibitor Combination Therapy for Dysphagia in Patients with Advanced Esophageal Cancer;Journal of Clinical Medicine;2024-08-15

4. Prognostic factors for esophageal respiratory fistula in unresectable esophageal squamous cell carcinoma treated with radiotherapy;Scientific Reports;2024-07-26

5. Survival outcome of esophagectomy and chemoradiotherapy for resectable esophageal squamous cell carcinoma in patients >75 years of age;Thoracic Cancer;2024-06-19